Back

Preclinical assessment of transcatheter-delivered expandable endoluminal polymeric graft fabricated by electrospinning of microfiber

31 August 2024 (16:00 - 16:50)
Organised by: Logo
Congress Presentation Part of: Peripheral artery disease: endovascular and open treatments Intervention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Kotaro Miyashita

University of Galway, Galway (Ireland)

7 More presentations in this session

Presentation thumbnail
Clinical impact of serum cholinesterase level on clinical outcomes in patients with lower extremity artery disease undergoing endovascular treatment
Doctor H. Shimono (Kagoshima, JP)
Abstract Slides Video
Presentation thumbnail
Patient and procedural characteristics of successful endovascular procedures in the BEST-CLI Trial and their relationship to major adverse limb events
Associate Professor S. Kinlay (Boston, US)
Abstract Slides Video
Presentation thumbnail
Impact of the lower extremity arterial calcification score on clinical outcomes after drug-coated balloon angioplasty for de novo femoropopliteal artery disease
Doctor K. Kawamura (Okayama, JP)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of low-dose versus high-dose paclitaxel-coated balloons in patients with femoropopliteal lesions: an updated and meta-analysis.
Doctor M. Desouki (Minneapolis, US)
Abstract Slides Video
Presentation thumbnail
Factors affecting in-hospital clinical outcomes in patients with acute limb ischemia undergoing endovascular therapy or fogarty thrombectomy: a large-scale analysis based on the JROAD-DPC database
Doctor T. Ozawa (Kyoto, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Peripheral artery disease: endovascular and open treatments

The Event

Event poster

ESC Congress 2024

31 August 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Functional hemodynamic and wall shear stress assessment of a novel endoluminal fibrillated polymeric scaffold up to full resorption within 12 months in a preclinical in-vivo setting
thumbnail
Congress Presentation
VasCraft: new decellularized and re-endothelialized human vascular graft produced by tissue engineering for use in arterial bypass
thumbnail
Congress Presentation
VasCraft: a human decellularized and re-endothelialized tissue-engineered vascular graft for coronary arterial revascularization

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources